Drugs & Targets Predictive Oncology, UPMC partner to establish AI approach to ovarian cancer July 26, 2019Vol.45 No.30
Drugs & Targets FDA requests Allergan voluntarily recall some breast implants July 26, 2019Vol.45 No.30
Drugs & Targets Australian regulator conditionally OKs expanded uses for Keytruda July 19, 2019Vol.45 No.29
Drugs & Targets FDA approves expanded indication for FoundationOneCDx as a companion diagnostic for Lynparza July 12, 2019Vol.45 No.28
Drugs & Targets European Commission approves Libtayo for advanced cutaneous squamous cell carcinoma July 05, 2019Vol.45 No.27
Drugs & Targets FDA approves Darzalex + lenalidomide and dexamethasone in multiple myeloma patients ineligible for transplant June 28, 2019Vol.45 No.26